0001498382 2026-09-10 2026-09-10 true 0001498382 TuHURA Biosciences, Inc./NV 8-K/A 2026-09-10 NV 001-37823 99-0360497 10500 University Center Dr. Suite 110 Tampa FL 33612 (813) 875-6600 false false false false Common Stock, $0.001 par value per share HURA NASDAQ false This Form 8-K/A (Amendment No. 1) is being filed solely to add a new third paragraph to Item 5.02 of the Form 8-K filed on September 16, 2026 (the “Original 8-K”) in order to provide the following additional information regarding the Inducement Plan (as defined in the Original 8-K): (i) the Company has not yet, as of the date of the adoption of the Inducement Plan, granted any equity awards under the Inducement Plan, (ii) all grants of equity awards made under the Inducement Plan will be announced by the Company in a press release in accordance with Nasdaq Listing Rule 5635(c)(4), (iii) the Board of Directors of the Company currently expects that all equity awards granted under the Inducement Plan will be granted to new employees in the form of stock option grants that will have an exercise price equal to or greater than the closing price of the Company’s common stock on the date of grant, and (iv) the shares reserved for issuance under the Inducement Plan will not become issued and outstanding unless and until the stock options issued under the Inducement Plan to new employees become vested and are exercised. No other changes to the Original 8-K are being made by this Form 8-K/A (Amendment No. 1).